BASI Financial Facts

Operating income (loss): 256K
Income tax benefit: -15K
See Full Income Statement

Accounts payable: 3.37M
Total shareholders' equity: 9.84M
See Full Balance Sheet

Bioanalytical Systems (BASI) Earnings

  |   Expand Research on BASI
Next EPS Date 5/15/15 *Est. EPS Growth Rate -75.0% *Last Qtr.
Average EPS % Beat Rate -125.0% Revenue Growth Rate -5.9% *Last Qtr.
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/12/15 Q115 $0.01N/A N/A $5.85M$6.22M N/A Details
12/22/14 Q414 -$0.02N/A N/A $6.42M$5.51M N/A Details
8/14/14 Q314 $0.02N/A N/A $6.03M$5.6M N/A Details
5/15/14 Q214 -$0.03N/A N/A $5.91M$5.16M N/A Details
2/13/14 Q114 $0.04N/A N/A $6.22M$5.8M N/A Details
12/24/13 Q413 $0.03N/A N/A $5.51M$6.54M N/A Details
10/18/13 Q313 $0.07$0.01 +$0.06$5.6M$5.65M N/A Details
5/15/13 Q213 -$0.02$0.01 -$0.03$5.16M$5.74M N/A Details